![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 12")
FDA Grants Cannabis Extract VER-01 Breakthrough Therapy Status for Pain
The FDA has awarded Breakthrough Therapy Designation to VER-01, a pharmaceutical-grade cannabis extract for chronic low back pain. This marks the first FDA breakthrough therapy cannabis designation for pain treatment, backed by Phase 3 trials showing…
New Study Suggests Cannabinoids May Offer Relief for Chronic Pain Conditions Including …
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchCBDTHCMedical CannabisChronic PainSafety Why This Matters Clinicians need this evidence to make informed…
Boxer Derek Chisora Says Medical Cannabis Helps Combat Chronic Pain After 50 Fights
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainMental HealthIndustryResearchPolicySafetyAnxiety Why This Matters Clinicians treating athletes and patients with…
Former Boxer Derek Chisora Advocates for Medical Cannabis Access to Manage Chronic Pain
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainMedical CannabisPolicyPatient EducationChronic PainAdvocacyHealthcare Why This Matters Clinicians treating patients…
FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01 for Chronic Low …
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainResearchPolicyIndustryNeurologySafetyBreakthrough Therapy Clinical Summary # Clinical Summary The FDA's…
The First Cannabis Drug to Earn FDA Breakthrough Therapy Status for Pain`
The FDA has granted Breakthrough Therapy Designation to VER-01, a full-spectrum cannabis extract, after two Phase 3 RCTs showed significant pain reduction in patients with chronic low back pain. VER-01 outperformed opioids on both pain relief and…
Study Explores Medical Cannabis for Opioid Reduction in Chronic Pain Patients When Cost …
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchSafetyPolicyAnxietyMental HealthDosing Why This Matters As opioid-related harms remain a major public…
Cannabis Therapy Associated With Sustained Declines in Opioid Use Among Chronic Pain Patients
✦ New CED Clinical Relevance #82 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchCBDTHCSafetyMental HealthPolicy Why This Matters Clinicians managing chronic pain patients on opioids…
New Trial: 1:1 THC:CBD Oil Reduces Fibromyalgia Pain and Improves Sleep
A new double-blind, placebo-controlled trial found that cannabis oil with equal amounts of THC and CBD meaningfully reduced pain and improved sleep in fibromyalgia patients. The trial, conducted across three Australian research institutions, achieved a…
Medical Marijuana Helps Pain Patients Reduce Use Of Opioids, New Study Shows
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchOpioidsMedical MarijuanaAgingSafetyAlternative Medicine Why This Matters Clinicians managing chronic…